MYDA Advisors LLC - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 142 filers reported holding KURA ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 1.53 and the average weighting 0.3%.

Quarter-by-quarter ownership
MYDA Advisors LLC ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$729,600
-13.8%
80,0000.0%0.24%
-7.1%
Q2 2023$846,400
+246.0%
80,000
+300.0%
0.25%
+173.1%
Q1 2023$244,600
-1.5%
20,0000.0%0.09%
-39.2%
Q4 2022$248,200
-9.1%
20,0000.0%0.15%
+19.5%
Q3 2022$273,000
-25.6%
20,0000.0%0.13%
+24.3%
Q2 2022$367,000
+14.0%
20,0000.0%0.10%
-18.9%
Q1 2022$322,00020,0000.13%
Other shareholders
KURA ONCOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,849,947$16,871,5179.37%
Prosight Management, LP 1,932,456$17,623,9995.58%
ACUTA CAPITAL PARTNERS, LLC 702,093$6,403,0884.29%
ALETHEA CAPITAL MANAGEMENT, LLC 350,445$3,196,0583.93%
SUVRETTA CAPITAL MANAGEMENT, LLC 7,335,845$66,902,9063.62%
Affinity Asset Advisors, LLC 856,535$7,811,5992.20%
TCG Crossover Management, LLC 1,423,642$12,983,6151.91%
EcoR1 Capital, LLC 5,806,871$52,958,6641.79%
BVF INC/IL 6,730,983$61,386,5651.66%
DAFNA Capital Management LLC 550,784$5,023,1501.56%
View complete list of KURA ONCOLOGY INC shareholders